154 related articles for article (PubMed ID: 15595413)
1. Anti-diabetic activities of fucosterol from Pelvetia siliquosa.
Lee YS; Shin KH; Kim BK; Lee S
Arch Pharm Res; 2004 Nov; 27(11):1120-2. PubMed ID: 15595413
[TBL] [Abstract][Full Text] [Related]
2. Anti-oxidant activities of fucosterol from the marine algae Pelvetia siliquosa.
Lee S; Lee YS; Jung SH; Kang SS; Shin KH
Arch Pharm Res; 2003 Sep; 26(9):719-22. PubMed ID: 14560919
[TBL] [Abstract][Full Text] [Related]
3. Anti-adipogenic activity of the edible brown alga Ecklonia stolonifera and its constituent fucosterol in 3T3-L1 adipocytes.
Jung HA; Jung HJ; Jeong HY; Kwon HJ; Kim MS; Choi JS
Arch Pharm Res; 2014 Jun; 37(6):713-20. PubMed ID: 24014306
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
5. Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma.
Takiguchi Y; Wada K; Nakashima M
Eur J Pharmacol; 1992 May; 215(2-3):289-91. PubMed ID: 1396993
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of fucosterol isolated from the edible brown algae, Ecklonia stolonifera and Eisenia bicyclis, on tert-butyl hydroperoxide- and tacrine-induced HepG2 cell injury.
Choi JS; Han YR; Byeon JS; Choung SY; Sohn HS; Jung HA
J Pharm Pharmacol; 2015 Aug; 67(8):1170-8. PubMed ID: 25773602
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Mycobacterium tuberculosis growth by saringosterol from Lessonia nigrescens.
Wächter GA; Franzblau SG; Montenegro G; Hoffmann JJ; Maiese WM; Timmermann BN
J Nat Prod; 2001 Nov; 64(11):1463-4. PubMed ID: 11720535
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera.
Jung HA; Ali MY; Choi RJ; Jeong HO; Chung HY; Choi JS
Food Chem Toxicol; 2016 Mar; 89():104-11. PubMed ID: 26825629
[TBL] [Abstract][Full Text] [Related]
9. New cytotoxic oxygenated fucosterols from the brown alga Turbinaria conoides.
Sheu JH; Wang GH; Sung PJ; Duh CY
J Nat Prod; 1999 Feb; 62(2):224-7. PubMed ID: 10075746
[TBL] [Abstract][Full Text] [Related]
10. Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
Isogai S; Inokuchi T; Ohe K
Diabetes Res Clin Pract; 1995 Nov; 30(2):111-6. PubMed ID: 8833631
[TBL] [Abstract][Full Text] [Related]
11. Fucosterol, isolated from Ecklonia stolonifera, inhibits adipogenesis through modulation of FoxO1 pathway in 3T3-L1 adipocytes.
Lee JH; Jung HA; Kang MJ; Choi JS; Kim GD
J Pharm Pharmacol; 2017 Mar; 69(3):325-333. PubMed ID: 28134973
[TBL] [Abstract][Full Text] [Related]
12. The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats.
Itagaki I; Shimizu K; Kamanaka Y; Ebata K; Kikkawa R; Haneda M; Shigeta Y
Diabetes Res Clin Pract; 1994 Oct; 25(3):147-54. PubMed ID: 7851268
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes.
Sobajima H; Aoki T; Sassa H; Suzuki T; Taniko K; Makino M; Mizuno K; Suzuki T
Pharmacology; 2001 May; 62(4):193-9. PubMed ID: 11359994
[TBL] [Abstract][Full Text] [Related]
14. A succinylanthranilic acid ester and other bioactive constituents of Jolyna laminarioides.
Atta-Ur-Rahman ; Choudhary MI; Majeed A; Shabbir M; Ghani U; Shameel M
Phytochemistry; 1997 Dec; 46(7):1215-8. PubMed ID: 9423291
[TBL] [Abstract][Full Text] [Related]
15. Effect of epalrestat, an aldose reductase inhibitor, on the generation of oxygen-derived free radicals in neutrophils from streptozotocin-induced diabetic rats.
Kashima K; Sato N; Sato K; Shimizu H; Mori M
Endocrinology; 1998 Aug; 139(8):3404-8. PubMed ID: 9681489
[TBL] [Abstract][Full Text] [Related]
16. Fucosterol from an Edible Brown Alga
Oh JH; Choi JS; Nam TJ
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30301140
[TBL] [Abstract][Full Text] [Related]
17. Urinary sorbitol measurement and the effect of an aldose reductase inhibitor on its concentration in the diabetic state.
Nakano I; Tsugawa T; Shinohara R; Watanabe F; Fujita T; Nagata M; Kato T; Himeno Y; Kobayashi T; Fujiwara K; Nagata M; Itoh M; Nagasaka A
J Diabetes Complications; 2003; 17(6):337-42. PubMed ID: 14583178
[TBL] [Abstract][Full Text] [Related]
18. Health benefit of fucosterol from marine algae: a review.
Abdul QA; Choi RJ; Jung HA; Choi JS
J Sci Food Agric; 2016 Apr; 96(6):1856-66. PubMed ID: 26455344
[TBL] [Abstract][Full Text] [Related]
19. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.
Kikkawa R; Hatanaka I; Yasuda H; Kobayashi N; Shigeta Y; Terashima H; Morimura T; Tsuboshima M
Diabetologia; 1983 Apr; 24(4):290-2. PubMed ID: 6407887
[TBL] [Abstract][Full Text] [Related]
20. Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats.
Kikkawa R; Hatanaka I; Yasuda H; Kobayashi N; Shigeta Y
Metabolism; 1984 Mar; 33(3):212-4. PubMed ID: 6420645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
